Global Stretch Marks Treatment Market Overview 2023-2028

Stretch marks, also known as striae, are narrow streaks or lines that develop on the skin when it undergoes rapid stretching due to pregnancy, sudden weight gain, or growth spurts. They commonly appear on areas, such as abdomen, thighs, hips, breasts, and upper arms. They can be treated through various medical and cosmetic procedures that reduce or eliminate the appearance of stretch marks on the skin. As they assist in boosting self-confidence and enhancing skin appearance by providing smoother and more toned skin, the demand for stretch marks treatment is rising across the globe.

The global stretch marks treatment market size reached US$ 2.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.1 Billion by 2028, exhibiting a growth rate (CAGR) of 6.1% during 2023-2028.

Global Stretch Marks Treatment Market Trends and Drivers:

At present, the increasing demand for topical creams and lotions to reduce the visibility of stretch marks represents one of the primary factors propelling the market growth. Apart from this, the rising awareness among consumers about enhanced physical appearance is supporting the market growth. In addition, the growing prevalence of stretch marks due to obesity and hormonal changes among individuals is offering a positive market outlook. Additionally, the increasing development of innovative stretch marks treatment procedures, such as laser therapy, that have the ability to stimulate collagen production and aid in skin repair is contributing to the growth of the market. Furthermore, the growing popularity of combination therapies is positively influencing the market.

Global Stretch Marks Treatment Market 2023-2028 Analysis and Segmentation:

Top Key Players covered in this report are: Alliance Pharma PLC, basq NYC, Bayer AG, Candela Corporation, Clarins, Dermaclara, E.T. Browne Drug Co. Inc., Helix Biomedix Inc., HRA Pharma (Perrigo Company plc), Laboratoires Expanscience, Union-Swiss (Pty) Ltd and Weleda

The report segmented the market on the basis of region, treatment, distribution channel and end user.

Breakup by Treatment:

• Topical Products
• Creams
• Oils and Serum
• Lotions
• Lasers
• Fractional Lasers
• Pulse-Dye Lasers
• Others
• Microdermabrasion
• Others

Breakup by Distribution Channel:

• Institutional
• Retail
• Supermarkets and Hypermarkets
• Specialist Retailers
• Medical Retailers
• Online Stores
• Others

Breakup by End User:

• Hospitals and Clinics
• Home Use
• Specialty Dermatology Centers
• Others

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

Key highlights of the report:

• Market Performance (2017-2022)
• Market Outlook (2023- 2028)
• Porters Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.

Contact Us:

IMARC Services Private Limited.

134 N 4th St. Brooklyn, NY 11249, USA

Email:Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800